Discrete LQR control for determining the optimal inhibitor dose level for an anti-angiogenic therapy based on a mathematical model of tumor growth dynamics.
Discrete LQR control for determining the optimal inhibitor dose level for an anti-angiogenic therapy based on a mathematical model of tumor growth dynamics.
MIT License